Literature DB >> 24480417

Neuroinflammation in the fetus exposed to maternal obsessive-compulsive disorder during pregnancy: a comparative study on cord blood tumor necrosis factor-alpha levels.

Faruk Uguz1, Erdem Onder Sonmez2, Mine Sahingoz3, Zeynel Gokmen4, Mustafa Basaran5, Kazim Gezginc6, Gulsum Sonmez7, Nazmiye Kaya8, Emre Yilmaz9, Sami Sait Erdem10, Hasan Haluk Dulger11, Humeyra Cicekler12, Erkan Tasyurek13.   

Abstract

OBJECTIVE: The relationship between maternal psychiatric disorders and fetal neurodevelopment is unclear. Obsessive-compulsive disorder (OCD) is relatively frequent during pregnancy. The study aimed to investigate whether maternal OCD during pregnancy affects fetal circulating tumor necrosis factor-alpha (TNF-α) levels, an important pro-inflammatory cytokine, by comparing cord blood TNF-α levels in newborn infants of women with and without OCD.
METHODS: The study sample included 7 women with OCD and 30 healthy women. OCD and other psychiatric diagnoses were screened by means of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. The blood sample for the determination of TNF-α level was obtained from the umbilical cord during delivery.
RESULTS: Cord blood TNF-α levels in newborn infants exposed to maternal OCD were significantly higher compared to non-exposed infants. Maternal anxiety symptom level was found to positively correlate with cord blood TNF-α levels in newborn infants of women with OCD.
CONCLUSION: The study results imply that maternal OCD during pregnancy may lead to neuroinflammation in the developing fetal brain through higher levels of circulating TNF-α.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24480417     DOI: 10.1016/j.comppsych.2013.12.018

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  5 in total

1.  Evaluation of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Fetal Cord Blood of Depressed Mothers.

Authors:  Mehmet Akif Camkurt; Ebru Fındıklı; Murat Bakacak; Fatma İnanç Tolun; Mehmet Fatih Karaaslan
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

Review 2.  Individualized Immunological Data for Precise Classification of OCD Patients.

Authors:  Hugues Lamothe; Jean-Marc Baleyte; Pauline Smith; Antoine Pelissolo; Luc Mallet
Journal:  Brain Sci       Date:  2018-08-09

3.  Effect of Maternal Depression on Brain-derived Neurotrophic Factor Levels in Fetal Cord Blood.

Authors:  Erdem Onder Sonmez; Faruk Uguz; Mine Sahingoz; Gulsum Sonmez; Nazmiye Kaya; Mehmet Akif Camkurt; Zeynel Gokmen; Mustafa Basaran; Kazim Gezginc; Sami Sait Erdem; Hasan Haluk Dulger; Erkan Tasyurek
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

Review 4.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 5.  Cytokine profile of pediatric patients with obsessive-compulsive and/or movement disorder symptoms: A review.

Authors:  Rebecca Alison Fabricius; Camilla Birgitte Sørensen; Liselotte Skov; Nanette Mol Debes
Journal:  Front Pediatr       Date:  2022-08-19       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.